Lutonix Global SFA Registry

CompletedOBSERVATIONAL
Enrollment

691

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2016

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Lutonix Drug Coated Balloon

Subject will receive treatment with the Lutonix Drug Coated Balloon

Trial Locations (23)

1090

Allgemeines Krankenhaus Wien, Vienna

2020

ZNA Campus Middelheim, Antwerp

5001

Kantonsspital Aarau, Aarau

14100

AO Cardinal Massaia, Asti

20097

IRCCS Policlinico San Donato, San Donato Milanese

21079

CHU Le Bocage, Dijon

23035

Azienda Ospedaliera della Valtellina e dalla Valchiavenna, Sondalo

26504

University General Hospital of Patras, Pátrai

59759

Karolinen Hospital Huesten, Arnsberg

80331

Diakoniewerk Muenchen, München

92637

Klinikum Weiden, Weiden

94234

Kreiskrankenhaus Viechtach, Viechtach

96515

Medinos Kliniken Sonneberg, Sonneberg

Unknown

AO Ordine Mauriziano, Torino

85-168

Szpital Uniwersytecki nr 2 im. Biziel, Bydgoszcz

61-848

Szpital Kliniczny Przemienienia Panskiego, Poznan

87-100

Voivodship Specialist Hospital, Torun

08036

Hospital Clinico Barcelona, Barcelona

L7 8XP

Royal Liverpool, Liverpool

SE1 7EH

St Thomas' Hospital, London

M13 9WL

Manchester Royal Infirmary, Manchester

M23 9LT

Wythenshawe Hospital, Manchester

WE7 7DN

Freeman Hospital, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Bard Ltd

INDUSTRY

lead

C. R. Bard

INDUSTRY

NCT01864278 - Lutonix Global SFA Registry | Biotech Hunter | Biotech Hunter